Association of the NAD(P)H:Quinone Oxidoreductase (NQO1) 609C→T Polymorphism with Lung Cancer Risk among Male Smokers
Open Access
- 1 September 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (9), 2275-2276
- https://doi.org/10.1158/1055-9965.epi-05-0375
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based studyCarcinogenesis: Integrative Cancer Research, 2004
- Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissionsCarcinogenesis: Integrative Cancer Research, 2004
- Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in TaiwanLung Cancer, 2003
- NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for JapaneseInternational Journal of Clinical Oncology, 2002
- NAD(P)H: QUINONE OXIDOREDUCTASE POLYMORPHISM AND LUNG CANCER IN TAIWANJournal of Toxicology and Environmental Health, Part A, 1999
- Genotype-phenotype relationships in studies of a polymorphism in NAD(P)HPharmacogenetics, 1999
- Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smokingPharmacogenetics, 1995
- Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B.Environmental Health Perspectives, 1994
- The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male SmokersThe New England Journal of Medicine, 1994
- The alpha-tocopherol, beta-carotene lung cancer prevention study: Design, methods, participant characteristics, and complianceAnnals of Epidemiology, 1994